Drug Profile


Alternative Names: Eptastigmine tartrate; Heptylphysostigmine; Heptylstigmine tartrate; L 693487; MF 201

Latest Information Update: 08 Jun 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mediolanum
  • Developer Banyu; Mediolanum
  • Class Indole alkaloids; Nootropics; Phenylcarbamates; Small molecules
  • Mechanism of Action Acetylcholinesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 08 Jun 1999 A study has been added to the adverse events and therapeutic trials sections
  • 29 Jan 1999 Discontinued-III for Alzheimer's disease in Italy (PO)
  • 29 Jan 1999 Discontinued-III for Alzheimer's disease in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top